Revvity (RVTY) Stock Forecast & Price Target

$102.09
-0.59 (-0.57%)
(As of 04/25/2024 ET)

Revvity Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 12 Analyst Ratings

Analysts' Consensus Price Target

$118.91
16.47% Upside
High Forecast$147.00
Average Forecast$118.91
Low Forecast$95.00
TypeCurrent Forecast
4/26/23 to 4/25/24
1 Month Ago
3/27/23 to 3/26/24
3 Months Ago
1/26/23 to 1/26/24
1 Year Ago
4/26/22 to 4/26/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
N/A
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
Buy
6 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
N/A
Hold
6 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
N/A
Consensus Price Target$118.91$118.91$116.10N/A
Predicted Upside16.47% Upside12.31% Upside15.04% UpsideN/A
Get Revvity Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for RVTY and its competitors with MarketBeat's FREE daily newsletter.

RVTY Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

RVTY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Revvity Stock vs. The Competition

TypeRevvityMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.68
2.49
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside15.81% Upside1,062.27% Upside10.01% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/2/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$95.00 ➝ $110.00+4.35%
2/2/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$106.00 ➝ $127.00+18.68%
2/2/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$110.00 ➝ $126.00+17.75%
1/25/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$92.00 ➝ $105.00-2.92%
1/16/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$105.00 ➝ $125.00+12.82%
1/4/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeIn-Line ➝ Outperform$88.00 ➝ $125.00+19.02%
12/19/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageEqual Weight$95.00-6.23%
12/13/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoveragePeer Perform
10/31/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$120.00 ➝ $105.00+27.07%
10/17/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$130.00 ➝ $110.00+4.17%
9/28/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$133.00+21.96%
8/2/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$165.00 ➝ $147.00+19.87%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 08:07 PM ET.

RVTY Price Target - Frequently Asked Questions

What is Revvity's consensus rating and price target?

According to the issued ratings of 12 analysts in the last year, the consensus rating for Revvity stock is Moderate Buy based on the current 6 hold ratings and 6 buy ratings for RVTY. The average twelve-month price prediction for Revvity is $118.91 with a high price target of $147.00 and a low price target of $95.00. Learn more on RVTY's analyst rating history.

Do Wall Street analysts like Revvity more than its competitors?

Analysts like Revvity less than other Medical companies. The consensus rating score for Revvity is 2.50 while the average consensus rating score for medical companies is 2.68. Learn more on how RVTY compares to other companies.

Does Revvity's stock price have much upside?

According to analysts, Revvity's stock has a predicted upside of 12.31% based on their 12-month stock forecasts.

What analysts cover Revvity?

Revvity has been rated by KeyCorp, Raymond James, and Stifel Nicolaus in the past 90 days.


Stock Ratings Reports and Tools

This page (NYSE:RVTY) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners